The significance of such efforts becomes apparent when considering PBK inhibition, which exhibits remarkable anti-tumor activity in pre-clinical models, but at the same time targets a protein that is crucial for neuronal self-renewal and protection against ischemic postconditioning in the heart and brain.182. This evidence concerns the gene PBK and neoplasm.